Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.
Stanford Medical Center, CA.
P
P
Greenberg
R
R
Negrin
A
A
Nagler
L
L
Souza
T
T
Donlon
D001854:Bone Marrow Cells; D002478:Cells, Cultured; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004341:Drug Evaluation; D016179:Granulocyte Colony-Stimulating Factor; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D003115:Colony-Stimulating Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor